ciprofloxacin has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Leukemia, Myelomonocytic, Chronic: A myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Josa Laorden, C | 1 |
| Gómez del Valle, C | 1 |
| Bucar Barjud, M | 1 |
| Amores Arriaga, MB | 1 |
| Torralba Cabeza, MA | 1 |
| Pérez Calvo, JI | 1 |
1 other study available for ciprofloxacin and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Septic shock due to Rhodococcus equi in a patient with chronic myelomonocytic leukemia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Diagnosis, Diffe | 2013 |